My Profile
Agnes Crane
Making a market in
Ideas
See all posts
Mon 30 Nov 2009 | 7:39 EST
You are here:
Home
>
Business & Finance
>
Stocks
> Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSS
Widgets
Mobile
Podcasts
Newsletters
Your View
Make Reuters My Homepage
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters
Officers and Directors For Pharmacyclics, Inc.
Pharmacyclics, Inc. (PCYC.O) (Consolidated Issue listed on NASDAQ Capital Market)
sector:
Healthcare
.
industry:
Biotechnology
ยท
View
PCYC
on other exchanges
As of 27 Nov 2009
1.85
USD
Price Change
+0.12
Percent Change
+6.94%
Analyst Recommendations
Research Another Stock:
Symbol Look-up
Independent Research
|
Broker Research
Summary
Biographies
Basic Compensation
Options Compensation
Name
Age
Since
Current Position
Buggy, Joseph
42
2007
Vice President - Research
Loury, David
53
2006
Vice President - Preclinical Sciences
Erdtmann, Rainer
46
2009
Vice President - Finance and Administration, Secretary
Mehta, Minesh
51
2008
Director
Bamdad, Cynthia
56
2008
Director
Smith, David
38
2008
Director
Adelman, Jason
40
2009
Director
Hamdy, Ahmed
44
2009
Chief Medical Officer
Duggan, Robert
65
2009
Chairman of the Board, Chief Executive Officer
Find out more about PCYC.O
Insider Trading